Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
21
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Celltrion Inc
•
17 Aug 2024 00:51
Merger Between Celltrion Inc and Celltrion Pharm Is Cancelled
Celltrion Inc announced that its proposed merger with Celltrion Pharm has been cancelled due to disapproval of this deal among an overwhelming...
Douglas Kim
Follow
373 Views
Share
bullish
•
Celltrion Inc
•
07 Aug 2024 20:14
Celltrion (068270 KS): 2Q24 Result- Biosimilar Sales Roar; Operating Profit Recovers Sequentially
Celltrion posted record high quarterly sales for the second consecutive quarter, with balanced growth in core and new biosimilar products....
Tina Banerjee
Follow
198 Views
Share
bullish
•
Celltrion Inc
•
02 Jul 2024 17:30
Alpha Generation Through Share Buybacks in Korea: Bi-Monthly (May and June 2024)
In this insight, we discuss the alpha generation through companies that have been buying back their shares in the Korean stock market in May and...
Douglas Kim
Follow
274 Views
Share
bullish
•
Celltrion Inc
•
28 May 2024 05:30
FnGuide Top 5 Plus Index Rebalance Preview: Celltrion Could Replace KT&G
Celltrion could replace KT&G in the FnGuide Top5 Plus Index in June. Passives will need to buy 1x ADV in Celltrion and sell 2x ADV in KT&G. There...
Brian Freitas
Follow
283 Views
Share
bullish
•
Celltrion Inc
•
10 May 2024 14:47
Celltrion (068270 KS): 1Q24 Result- Sales Hit Quarterly High; Profit Sinks on Merger Effect
Celltrion saw 23% sales growth in 1Q24 driven by Remsima in Europe. Profit is expected to improve in coming quarters as inventory is digested. The...
Tina Banerjee
Follow
361 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x